Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Synta Pharmaceuticals Corp
Synta Pharmaceuticals Corporation
Synta Pharmaceuticals Corp_20131212
  

Synta Pharmaceuticals Corp patents

Recent patent applications related to Synta Pharmaceuticals Corp. Synta Pharmaceuticals Corp is listed as an Agent/Assignee. Note: Synta Pharmaceuticals Corp may have other listings under different names/spellings. We're not affiliated with Synta Pharmaceuticals Corp, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "S" | Synta Pharmaceuticals Corp-related inventors




Date Synta Pharmaceuticals Corp patents (updated weekly) - BOOKMARK this page
01/07/16Compositions and methods for modulating c-rel-dependent cytokine production
06/25/15Method for treating b cell regulated autoimmune disorders
02/13/14Compounds for the treatment of proliferative disorders
11/15/12Compounds for the treatment of proliferative disorders
11/24/11Pyrimidine compounds and uses thereof
04/28/11Topical formulations for the treatment of psoriasis
10/07/10Il-12 modulatory compounds
09/09/10Disalt inhibitors of il-12 production
07/08/10Pyridine compounds
02/18/10Substituted fused-ring compounds for inflammation and immune-related uses
08/17/17Compounds for inflammation and immune-related uses
05/18/17Targeted therapeutics
03/02/17Targeted therapeutics
03/02/17Targeted therapeutics
02/23/17Targeted therapeutics
01/19/17Targeted therapeutics
12/29/16Targeted therapeutics
11/10/16Targeted cancer treatment by hsp90 inhibitors ganetespib and nvp-auy922
05/05/16Specific cancer treatment regimes with ganetespib
05/05/16Cancer therapy using a combination of a hsp90 inhibitory compounds and a egfr inhibitor
01/14/16Tricyclic triazole compounds that modulate hsp90 activity
01/07/16Imidazole compounds that modulate hsp90 activity
12/31/15Pre-selection of subjects for therapeutic treatment with an hsp90 inhibitory compound based on chemosensitive status
12/24/15Triazole compounds that modulate hsp90 activity
12/03/15Paclitaxel enhancer compounds
10/08/15Treating polycystic kidney disease with hsp90 inhibitory compounds
09/24/15Compounds for inflammation and immune-related uses
09/24/15Triazole compounds that modulate hsp90 activity
09/10/15Pre-selection of subjects for therapeutic treatment with an hsp90 inhibitor based on hypoxic status
07/02/15Triazole compounds that modulate hsp90 activity
06/25/15Method for inhibiting topoisomerase ii
06/04/15Treating cancer with hsp90 inhibitory compounds
06/04/15Formulation and dosing of hsp90 inhibitory compounds
05/21/15Targeted therapeutics
05/07/15Triazole compounds that modulate hsp90 activity
04/30/15Novel triazole compounds that modulate hsp90 activity
04/09/15Treating cancer with hsp90 inhibitory compounds
04/02/15Method for treating proliferative disorders associated with protooncogene products
03/19/15Compounds for the treatment of proliferative disorders
02/19/15Triazole derivatives as hsp90 inhibitors
01/29/15Transition metal complexes of a bis[thiohydrazide amide] compound
01/22/15Compounds for treating proliferative disorders
01/01/15Pyrrole compounds that modulate hsp90 activity
01/01/15Compounds for inflammation and immune-related uses
12/18/14Triazole compounds that modulate hsp90 activity
12/11/14Compounds that modulate hsp90 activity and methods for identifying same
11/27/14Polymorphs of n-malonyl-bis(n`-methyl-n`-thiobenzoylhydrazide)
11/20/14Compounds for treating proliferative disorders
11/06/14Administration of a bis(thiohydrazide amide) compound for treating cancers
10/23/14Combination therapy of hsp90 inhibitory compounds with mtor/p13k inhibitors
10/02/14Treating cancer with hsp90 inhibitory compounds
10/02/14Combination cancer therapy with an hsp90 inhibitor and an antimetabolite
09/11/14Cancer therapy using a combination of hsp90 inhibitors with topoisomerase i inhibitors
09/11/14Combination therapy of hsp90 inhibitors with braf inhibitors
09/04/14Vinyl-phenyl derivatives for inflammation and immune-related uses
08/28/14Substituted aromatic compounds for inflammation and immune-related uses
08/14/14Combination therapy of hsp90 inhibitory compounds with mek inhibitors
08/07/14Method for treating proliferative disorders associated with mutations in c-met
07/10/14Combination therapy of hsp90 inhibitory compounds with chk inhibitors
07/03/14Pyridylphenyl compounds for inflammation and immune-related uses
06/26/14Preselection of subjects for therapeutic treatment based on hypoxic status
06/19/14Compounds for inflammation and immune-related uses
05/22/14Method for treating inflammatory disorders
05/15/14Thiazole and thiadiazole compounds for inflammation and immune-related uses
05/15/14Treating cancer with an hsp90 inhibitory compound
Patent Packs
05/08/14Methods of identifying hsp90 inhibitors with less ocular toxicity
05/01/14Substituted biaryl compounds for inflammation and immune-related uses
04/24/14Preselection of subjects for therapeutic treatment with elesclomol based on hypoxic status
04/17/14Substituted pyridine compounds for inflammation and immune-related uses
04/17/14Compounds for inflammation and immune-related uses
04/03/14Imidazole compounds that modulate hsp90 activity
02/20/14Combination therapy of hsp90 inhibitory compounds with radiotherapy
02/20/14Prostate cancer therapy with hsp90 inhibitory compounds
02/13/14Compounds for inflammation and immune-related uses
02/13/14Hsp90 inhibitory compounds in treating jak/stat signaling-mediated cancers
02/06/14Compounds for inflammation and immune-related uses
01/02/14Combination breast cancer therapy with hsp90 inhibitory compounds
12/26/13Triazinone and diazinone derivatives useful as hsp90 inhibitors
12/19/13Method for treating infections
12/19/13Compounds for treating proliferative disorders
Patent Packs
12/12/13Combination therapy of hsp90 inhibitory compounds with proteasome inhibitors
11/28/13Thiazole and thiadiazole compounds for inflammation and immune-related uses
11/21/13Compounds for inflammation and immune-related uses
11/14/13Triazole compounds that modulate hsp90 activity
11/07/13Triazole compounds that modulate hsp90 activity
10/31/13Tetrazolyl-tetrahydropyridine compounds for inflammation and immune-related uses
10/03/13Pyrrole compounds that modulate hsp90 activity
09/12/13Heterocycle -aryl compounds for inflammation and immune-related uses
08/29/13Method of synthesizing substituted 2-alkyl phenols
07/04/13Cancer therapy using a combination of a hsp90 inhibitory compound and a topoisomerase ii inhibitor
07/04/13Formulation and dosing of hsp90 inhibitory compounds
06/27/13Compounds for inflammation and immune-related uses
06/20/13Cancer therapy using a combination of a hsp90 inhibitory compounds and a vegf inhibitor
06/13/13Method of treating non-small cell lung cancer with bis-(thiohydrazide)amide compounds
06/13/13Cancer therapy using a combination of a hsp90 inhibitory compounds and a egfr inhibitor
06/13/13Use of bis [thiohydrazide amide] compounds such as elesclomol for treating cancers
06/06/13Compounds for inflammation and immune-related uses
05/02/13Methods of identifying hsp90 inhibitors with less ocular toxicity
03/21/13Triazole compounds that modulate hsp90 activity
03/21/13Triazole compounds that modulate hsp90 activity
03/21/13Pyrazole compounds that modulate hsp90 activity
02/07/13Bis[thiohydrazide amide] compounds for treating leukemia
11/08/12Compounds for inflammation and immune-related uses
09/27/12Combination cancer therapy with hsp90 inhibitory compounds
09/13/12Combination cancer therapy with bis(thiohydrazide) amide compounds
09/06/12Compounds for inflammation and immune-related uses
08/16/12Compositions and methods for modulating c-rel-dependent cytokine production
08/09/12Triazole compounds that modulate hsp90 activity
08/02/12Compounds for inflammation and immune-related uses
07/26/12Benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses
Social Network Patent Pack
07/19/12Compounds for inflammation and immune-related uses
05/24/12Preselection of subjects for therapeutic treatment with elesclomol based on hypoxic status
05/24/12Preselection of subjects for therapeutic treatment based on hypoxic status
05/17/12Trizaole compounds that modulate hsp90 activity
04/26/12Triazole compounds that modulate hsp90 activity
04/19/12Compounds for treating proliferative disorders
03/15/12Pyridine compounds for inflammation and immune-related uses
03/15/12Hsp90 inhibitors for treating non-small cell lung cancer in wild-type egfr and/or kras patients
03/15/12Compounds for treating proliferative disorders
03/15/12Compounds for treating proliferative disorders
Patent Packs
02/16/12Compounds for the treatment of proliferative disorders
02/09/12Bis(thio-hydrazide amide) salts for treatment of cancers
01/26/12Method for treating b cell regulated autoimmune disorders
01/26/12Compounds for the treatment of proliferative disorders
12/29/11Method for treating non-hodkin's lymphoma
12/29/11Triazole compounds that modulate hsp90 activity
12/08/11Method for treating proliferative disorders associated with protooncogene products
12/01/11Il-12 modulatory compounds
12/01/11Compounds for treating proliferative disorders
12/01/11Bis(thio-hydrazide amide) formulation
10/06/11Compounds for treating proliferative disorders
10/06/11Combination with bis (thiohydrazide amides) for treating cancer
09/15/11Triazole compounds that modulate hsp90 activity
08/11/11Triazole compounds that modulate hsp90 activity
08/11/11Polymorphs of n-malonyl-bis(n'-methyl-n'-thiobenzoylhydrazide)
06/23/11Tricyclic triazole compounds that modulate hsp90 activity
06/23/11Novel crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt
06/16/11Pyrazole compounds that modulate hsp90 activity
05/05/11Triazole compounds that modulate hsp90 activity
04/28/11Process for preparing bis(thiohydrazide amides)
03/10/11Compounds for the treatment of proliferative disorders
03/03/11Compounds for inflammation and immune-related uses
02/24/11Method for treating infections
01/20/11Vinyl-phenyl derivatives for inflammation and immune-related uses
01/13/11Triazone compounds that modulate hsp90 activity
12/23/10Bis(thio-hydrazide amide) salts for treatment of cancers
12/09/10Compounds for inflammation and immune-related uses
11/25/10Triazinone and diazinone derivatives useful as hsp90 inhibitors
11/04/10Compounds for the treatment of proliferative disorders
11/04/10Method for treating inflammatory disorders
Patent Packs
11/04/10Paclitaxel enhancer compounds
10/28/10Substituted benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses
09/30/10Pyridylphenyl compounds for inflammation and immune-related uses
09/30/10Method for inhibiting topoisomerase ii
09/30/10Bis(thio-hydrazide amide) formulation
05/27/10Compounds for inflammation and immune-related uses
05/27/10Compounds for inflammation and immune-related uses
05/13/10Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss
04/15/10Triazole compounds that modulate hsp90 activity
04/15/10Compounds for the treatment of proliferative disorders
03/18/10Combination with bis (thiohydrazide amides) for treating cancer
03/18/10Pyrazole compounds that modulate hsp90 activity
10/08/09Fused hetrocyclic compounds
06/25/09Process for preparing mesylate salts of il-12 inhibitory compounds
04/09/09Method for treating cancer
12/12/13Combination therapy of hsp90 inhibitory compounds with proteasome inhibitors







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Synta Pharmaceuticals Corp in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Synta Pharmaceuticals Corp with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';